Stenting of the Patent Ductus Arteriosus

Katherine Price; Justin R Ryan; Howaida El-Said

doi:10.1016/j.iccl.2024.02.002

Stenting of the Patent Ductus Arteriosus

Interv Cardiol Clin. 2024 Jul;13(3):421-430. doi: 10.1016/j.iccl.2024.02.002. Epub 2024 Mar 22.

Authors

Katherine Price¹, Justin R Ryan², Howaida El-Said³

Affiliations

¹ Department of Pediatrics, Cincinnati Children's Hospital Medical Center, 3333 Burnett Avenue, Cincinnati, OH, USA.
² Webster Foundation 3D Innovations Lab, Rady Children's Hospital, 3020 Children's way, San Diego, CA 92123, USA.
³ Department of Pediatric Cardiology, Rady Children's Hospital, 3020 Children's way, San Diego, CA 92123, USA. Electronic address: helsaid@ucsd.edu.

PMID: 38839174
DOI: 10.1016/j.iccl.2024.02.002

Abstract

Since PDA stenting was first attempted in the early 1990s, significant technical advancements have improved outcomes and some centers have even transitioned to exclusive PDA stenting for all infants with duct-dependent pulmonary circulation. In addition to its use in infants with duct-dependent pulmonary circulation, PDA stenting has also been adapted as a percutaneous palliative option for suprasystemic pulmonary arterial hypertension and as a component of the hybrid procedure. In this article, the authors aim to review indications and outcomes for PDA stenting, describe the procedure, and discuss future directions.

Keywords: Complications of PDA stent; PDA stent; Single ventricle with pulmonary atresia.

Publication types

Review

MeSH terms

Cardiac Catheterization / methods
Ductus Arteriosus, Patent* / surgery
Humans
Palliative Care / methods
Stents*
Treatment Outcome